En savoir plus
Citryll Announces Appointments of Eduardo Bravo as CEO and Tim Schenk as CBO
Citryll, a clinical-stage biotech company developing...
Alliance Promotion Microbiote applauds the new legislation securing stool collection in France
The Alliance Promotion Microbiote (APM), a prominent...
Enterome announces first patient dosed in a Phase 1/2 trial with third OncoMimics™ immunotherapy, EO4010, in Metastatic Colorectal Cancer
Enterome today announces that the first patient was...
Enterome’s new OncoMimics™ immunotherapy, EO2463, demonstrates early efficacy and favorable safety in Phase 1/2 trial for indolent non-Hodgkin lymphoma
Enterome, a clinical-stage company developing...
Enterome announces sustained positive clinical outcomes with EO2401
HUBDAY Future of Retail & E-Commerce
Come & meet us !
France Digital Tour – Bordeaux
FRANKFURT DIGITAL FINANCE
Paris Fintech Forum